Scientific Misconduct An International Perspective

Scientific Misconduct
An International Perspective

An International Symposium

November 16, 1998
Warsaw - Poland

Introductory lecture

  • E. Skamene, Director of Research, McGill University Health Centre, Montreal, Canada,
    Conflict of Interest in the University - Industry Interactions

Plenary session
  • T. Tołłoczko, former Rector, The Medical University of Warsaw, Poland,
    Ethical Considerations in the Allocation of Scarce Medical Resources

  • L. Rhoades, Director, Division of Policy and Education, Office of Research Integrity, Department of Health and Human Services, Washington, USA,
    The American Experience: Lessons Learned

  • L. Schaffar, Chef du Service des programmes, INSERM, Paris, France,
    Responding to Allegations of Scientific Misconduct - The Procedure of INSERM

  • I. Evans, Research Strategy Manager, Medical Research Council, London, UK,
    Conduct Unbecoming: the MRC's Approach to Handling Allegations of Scientific Misconduct

  • G. Schneider, Director for Scientific and International Affairs, Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany,
    Safeguarding Good Scientific Practice - New Institutional Approaches in Germany

  • S. Lock, former editor, British Medical Journal, London, UK,
    Variations on a theme: a British Initiative with a Difference

  • D. Andersen, Dannish Committee for Scientific Dishonesty, Copenhagen, Denmark,
    From Case Management to Preventive Guidelines

  • D. Swituła, ASTRA Clinical Research Unit, Central Europe,
    Principles of Good Clinical Practice in Clinical Research

  • M.G. Hansson, Swedish Parliamentary Committee on Research Ethics, Stockholm, Sweden,
    Relying on Honesty When Protecting Scientific Integrity

  • P. Riis, Danish Committee for Scientific Dishonesty, Copenhagen, Denmark,
    Sociology and Psychology Within the Scope of Scientific Dishonesty